These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32215407)

  • 1. Influence of nanomedicine mechanical properties on tumor targeting delivery.
    Li Z; Xiao C; Yong T; Li Z; Gan L; Yang X
    Chem Soc Rev; 2020 Apr; 49(8):2273-2290. PubMed ID: 32215407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Strategies in Cancer Nanomedicine.
    Tong R; Kohane DS
    Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating tumor mechanics with nanomedicine for cancer therapy.
    Zhao Q; Chen J; Zhang Z; Xiao C; Zeng H; Xu C; Yang X; Li Z
    Biomater Sci; 2023 Jun; 11(13):4471-4489. PubMed ID: 37221958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine: a new frontier in cancer therapeutics.
    Lee PY; Wong KK
    Curr Drug Deliv; 2011 May; 8(3):245-53. PubMed ID: 21291378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers.
    Raza F; Zafar H; You X; Khan A; Wu J; Ge L
    J Mater Chem B; 2019 Dec; 7(48):7639-7655. PubMed ID: 31746934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
    Ullah R; Wazir J; Khan FU; Diallo MT; Ihsan AU; Mikrani R; Aquib M; Zhou X
    AAPS PharmSciTech; 2020 May; 21(4):132. PubMed ID: 32409932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential drug delivery nanosystems for improving tumor penetration.
    Peng F; Li R; Zhang F; Qin L; Ling G; Zhang P
    Eur J Pharm Biopharm; 2020 Jun; 151():220-238. PubMed ID: 32311427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors.
    Kim J; Cho H; Lim DK; Joo MK; Kim K
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boosting antitumor efficacy of nanoparticles by modulating tumor mechanical microenvironment.
    Zhang X; Zhang X; Yong T; Gan L; Yang X
    EBioMedicine; 2024 Jul; 105():105200. PubMed ID: 38876044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug targeting systems for cancer therapy: nanotechnological approach.
    Tigli Aydin RS
    Mini Rev Med Chem; 2015; 14(13):1048-54. PubMed ID: 25138089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening.
    Millard M; Yakavets I; Zorin V; Kulmukhamedova A; Marchal S; Bezdetnaya L
    Int J Nanomedicine; 2017; 12():7993-8007. PubMed ID: 29184400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Delivery in Cancer Therapy, Quo Vadis?
    Lu ZR; Qiao P
    Mol Pharm; 2018 Sep; 15(9):3603-3616. PubMed ID: 29553749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmable nanomedicine: synergistic and sequential drug delivery systems.
    Pacardo DB; Ligler FS; Gu Z
    Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Targeted Tumor Chemotherapy Based on Smart Nanomedicines.
    Qin SY; Zhang AQ; Zhang XZ
    Small; 2018 Nov; 14(45):e1802417. PubMed ID: 30247806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine Tumor Targeting.
    Lammers T
    Adv Mater; 2024 Jun; 36(26):e2312169. PubMed ID: 38361435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
    Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications.
    Ranganathan R; Madanmohan S; Kesavan A; Baskar G; Krishnamoorthy YR; Santosham R; Ponraju D; Rayala SK; Venkatraman G
    Int J Nanomedicine; 2012; 7():1043-60. PubMed ID: 22403487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulating Nanomedicine for Cancer Therapy.
    Liu Z; Jiang W; Nam J; Moon JJ; Kim BYS
    Nano Lett; 2018 Nov; 18(11):6655-6659. PubMed ID: 30185039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine: the promise and challenges in cancer chemotherapy.
    Naguib YW; Cui Z
    Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.